Breakout Ventures is a San Francisco-based venture capital firm founded in 2016, dedicated to investing in early-stage companies that harness the power of cells to develop solutions in human health and sustainability. The firm focuses on creative biosciences, where biology, chemistry, and technology converge to address complex challenges. Breakout Ventures supports bold founders throughout the entire lifecycle of their companies, from seed to scale, providing capital, industry connections, and mentorship to help them succeed.

Notable investments include Cytovale, Immusoft, Ecovative Design, and Twelve.